2004
Effectiveness Over Time of Varicella Vaccine
Vázquez M, LaRussa PS, Gershon AA, Niccolai LM, Muehlenbein CE, Steinberg SP, Shapiro ED. Effectiveness Over Time of Varicella Vaccine. JAMA 2004, 291: 851-855. PMID: 14970064, DOI: 10.1001/jama.291.7.851.Peer-Reviewed Original ResearchConceptsTime of vaccinationVaricella vaccineVaccine effectivenessCase subjectsPolymerase chain reaction test resultsVaricella-zoster virus DNACase-control studyReaction test resultsReports of outbreaksFirst yearBreakthrough diseaseImmunized groupsActive surveillancePossible confoundersPediatric practiceVaccinationVaccineVirus DNAMonthsMost casesGroup practiceChickenpoxAgeYear 2Year 1Case-control studies of the effectiveness of vaccines: validity and assessment of potential bias
Shapiro ED. Case-control studies of the effectiveness of vaccines: validity and assessment of potential bias. The Pediatric Infectious Disease Journal 2004, 23: 127-131. PMID: 14872178, DOI: 10.1097/01.inf.0000109248.32907.1d.Peer-Reviewed Original ResearchMeSH KeywordsAntibodies, BacterialBacterial CapsulesBiasCase-Control StudiesChild, PreschoolConfidence IntervalsFemaleHaemophilus InfectionsHaemophilus influenzae type bHaemophilus VaccinesHumansImmunityImmunization ScheduleInfantMalePolysaccharides, BacterialProbabilityReference ValuesReproducibility of ResultsSensitivity and SpecificityTreatment OutcomeVaccinationConceptsEffectiveness of vaccinesCase-control studyInvasive Hib infectionsHib vaccinePneumococcal infectionHib infectionsInvasive infectionsHaemophilus influenzae type bInvasive pneumococcal infectionsInfluenzae type bMonths of ageIdentical study designOverall 34Study 74S. pneumoniaeStreptococcus pneumoniaeVaccineInfectionStudy designHibType BPneumoniaeValid methodCasesPotential bias
2000
Viral strain identification in varicella vaccinees with disseminated rashes
LARUSSA P, STEINBERG S, SHAPIRO E, VAZQUEZ M, GERSHON A. Viral strain identification in varicella vaccinees with disseminated rashes. The Pediatric Infectious Disease Journal 2000, 19: 1037-1039. PMID: 11099082, DOI: 10.1097/00006454-200011000-00002.Peer-Reviewed Original ResearchConceptsVaricella-zoster virusBreakthrough varicellaVaccine strainVaricella vaccineVaccine-strain varicella-zoster virusWild-type VZV infectionLive attenuated varicella vaccineAttenuated varicella vaccineRecipients of vaccineOka vaccine strainDisseminated rashNatural varicellaVesicular rashPostvaccination periodVZV infectionClinical pictureZosteriform rashGeneralized rashSkin lesionsVaccine virusVaricellaRashZosterVaccineesWild-type virus
1998
Effectiveness of pneumococcal vaccine
Butler J, Spika J, Nichol K, Shapiro E, Breinan R. Effectiveness of pneumococcal vaccine. The Lancet 1998, 351: 1961. PMID: 9654289, DOI: 10.1016/s0140-6736(05)78647-5.Peer-Reviewed Original Research
1997
Vaccination for varicella--just do it!
Shapiro E, LaRussa P. Vaccination for varicella--just do it! JAMA 1997, 278: 1529-30. PMID: 9363975, DOI: 10.1001/jama.278.18.1529.Commentaries, Editorials and LettersVaccination for Varicella—Just Do It!
Shapiro E, LaRussa P. Vaccination for Varicella—Just Do It! JAMA 1997, 278: 1529-1530. DOI: 10.1001/jama.1997.03550180079042.Commentaries, Editorials and LettersMeSH KeywordsAdolescentAdultChickenpoxChickenpox VaccineChildChild, PreschoolHumansInfantRiskVaccinationConceptsVaricella vaccineVaccine-induced immunity wanesStrategy of immunizationDuration of protectionMonths of agePublic health servicesImmune childrenImmunization PracticesImmunity wanesUS FoodDrug AdministrationSusceptible adultsSusceptible individualsInfants 12Health servicesAmerican AcademyInfectious diseasesVaccineVaricellaAdvisory CommitteeAdultsConsiderable controversyChildrenVaccineesMorbidity
1991
The Protective Efficacy of Polyvalent Pneumococcal Polysaccharide Vaccine
Shapiro E, Berg A, Austrian R, Schroeder D, Parcells V, Margolis A, Adair R, Clemens J. The Protective Efficacy of Polyvalent Pneumococcal Polysaccharide Vaccine. New England Journal Of Medicine 1991, 325: 1453-1460. PMID: 1944423, DOI: 10.1056/nejm199111213252101.Peer-Reviewed Original ResearchConceptsInvasive pneumococcal infectionsPneumococcal polysaccharide vaccinePneumococcal vaccineProtective efficacyPneumococcal infectionCase patientsImmunocompetent patientsPolysaccharide vaccineVaccination historyHospital-based case-control studyPolyvalent pneumococcal polysaccharide vaccineSerious pneumococcal infectionsSite of hospitalizationVaccine protective efficacyPolyvalent pneumococcal vaccineCase-control studyProspective surveillanceRandomized trialsSterile sitesPatientsS. pneumoniaeMedical careStreptococcus pneumoniaeVaccineInfection
1984
A controlled evaluation of the protective efficacy of pneumococcal vaccine for patients at high risk of serious pneumococcal infections.
Shapiro E, Clemens J. A controlled evaluation of the protective efficacy of pneumococcal vaccine for patients at high risk of serious pneumococcal infections. Annals Of Internal Medicine 1984, 101: 325-30. PMID: 6380367, DOI: 10.7326/0003-4819-101-3-325.Peer-Reviewed Original ResearchConceptsIncreased risk of pneumococcal infectionRisk of pneumococcal infectionEfficacy of pneumococcal vaccineSystemic pneumococcal infectionPneumococcal infectionPneumococcal vaccineVaccine protective efficacyIncreased riskProtective efficacyCase-control studyOdds ratioVaccine efficacyHigh riskMatched controlsPatientsInfectionConfounding variablesEfficacyVaccine